Quarter Financials
BioCryst Pharmaceuticals, Inc. (BCRX)
$8.12
+0.18 (+2.27%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | -72 | -43 | -59 | -74 | -18 | -59 | -43 | -64 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -1,455 | -1,383 | -1,341 | -1,282 | -1,208 | -1,190 | -1,131 | -1,088 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | -1 | -0 | -0 | -0 | -1 | -0 | -1 | -0 |
|---|
| Net PPE | 9 | 15 | 16 | 16 | 9 | 13 | 11 | 11 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | - | - | - | -10 | -38 | -101 | -105 | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|